NeuroQure's ASD Insight autism risk screening test enables risk assessment in children as young as newborns. This is far earlier than traditional behavioral evaluations.
By identifying risk months or even years before behavioral signs emerge, patients have the potential to better manage autism spectrum disorders. In fact, early intervention leads to a formative increase in IQ, around ~10 points higher.
This makes ASD Insight an invaluable test when looking at ways to intervene sooner.
While not an autism prenatal testing option, the ASD Insight test can be performed just days after birth, potentially enabling early intervention autism strategies and improving autism treatment efficacy.
Our ASD Insight test detects a cellular signal shared by individuals with:
High-potency single-gene (monogenic) ASD syndromes (e.g., Fragile X, Tuberous Sclerosis)
High-throughput screen detects calcium signaling dysfunction in typical sporadic autism spectrum disorder
Is the risk of autism detected in NeuroQure's ASD Insight test?
Can ASD Insight be used as an autism prenatal test?
How does ASD Insight differ from genetic screenings for autism?
Order your NeuroQure early detection autism risk test today.